Autres langues Pharmesis International Ltd.

Actions

BFK

SG1BH6000003

Marché Fermé - Singapore S.E. Autres places de cotation 02:58:51 29/04/2024			Varia. 5j.	Varia. 1 janv.
0,111 ^SGD	-7,50 %		-7,50 %	+13,27 %

15/04	La perte attribuable de Pharmesis pour 2023 s'aggrave	MT
15/04	Pharmesis International Ltd. annonce le départ à la retraite de Mme Lin Yimin en tant qu'administrateur	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pharmesis’ Attributable Loss for 2023 Widens	15/04
Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director	15/04
Pharmesis Launches New Product Line	26/03
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months and Full Year Ended 31 December 2023	28/02
Pharmesis International Ltd. Announces Changes to the Composition of the Board and Board Committees	29/09/23
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	14/08/23
Pharmesis International Flags Losses for H1	09/08/23
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023	08/08/23
Pharmesis International Ltd. Announces Management Resignations	31/07/23
Pharmesis International Ltd. Appoints Lin Yimin as Non-Independent Non-Executive Director and A Member of Audit Committee	31/07/23
Pharmesis International Ltd. Announces Temporary Work Stoppages at its Manufacturing Facilities Located in Gulin County, Luzhou City, Sichuan Province	27/07/23
Pharmesis International Issues 4.6 Million Shares to Two Subscribers	06/04/23
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares	29/03/23
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers	21/03/23
Pharmesis International Expects Loss in H2, FY22	28/02/23
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/02/23
Pharmesis International's Attributable Loss Widens in H1	15/08/22
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22
Pharmesis International to Post Losses in H1 Amid Lower Sales	08/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pharmesis International Ltd.

Actions

BFK

SG1BH6000003

Autres langues

Filtres